You are an expert legal evaluator assessing responses about the EU AI Act. You will evaluate two responses to the same question completely independently, without comparing them to each other.

**Your Task:**
1. Compare each response against the provided expert legal analysis (groundtruth)
2. Use web_search to verify any specific claims, article numbers, or provisions mentioned in each response
3. Evaluate each response separately and independently on the rating categories below - be strictly neutral and objective
4. Provide exactly one sentence / one expression justification per rating in concise manner
5. Create a single artifact with your ratings and justifications

**Question Asked:** 
"How does the EU AI Act's risk classification system interact with existing Medical Device Regulations for AI-powered healthcare tools, and what are the implications for transparency requirements?"

**Expert Legal Analysis (Groundtruth):**
"The EU Artificial Intelligence Act (2024): Implications for healthcare" Hannah van Kolfschooten, Janneke van Oirschot 2024
[This contains authoritative legal analysis from peer-reviewed research that should be used as the benchmark for evaluating factual accuracy and completeness]

**Response A:**
"Summary:
The EU AI Act's risk classification system, outlined in Article 34, interacts with existing Medical Device Regulations (MDR) for AI-powered healthcare tools by providing a harmonized framework for assessing and addressing risks. This interaction ensures consistency in risk management across both regimes, while also enhancing transparency requirements.

Step-by-step reasoning:
The EU AI Act introduces a four-level risk classification system, with categories of low, medium, high, and unacceptable. Article 34(2) specifies that AI systems will be assigned a level based on their ability to cause harm or manipulate the physical world. For AI-powered healthcare tools, this means that devices will be assessed for their potential to cause physical or health-related harm, such as patient safety or clinical treatment outcomes.

The MDR, on the other hand, classifies medical devices into four categories (Class I, II, IIa, and III) based on their level of risk, including the potential for patient harm or health-related risk. Article 13(1) MDR requires medical devices to be classified as one of the four classes, with higher classes indicating higher risks.

When AI-powered healthcare tools are subject to both regimes, they will be classified under the MDR according to their level of risk, as per Article 13(2) MDR. The EU AI Act's risk classification system, on the other hand, will be applied in conjunction with the MDR classification. This means that AI-powered healthcare tools will be assessed for both their potential to cause physical or health-related harm (as per MDR) and their level of risk according to the EU AI Act's classification system.

The implications for transparency requirements are significant. Article 26(4) EU AI Act requires providers of high-risk AI systems, including those in healthcare, to provide "detailed documentation on the technical design and functionality" of the system, as well as any "mitigation measures" taken to address identified risks. In addition, Article 26(6) obliges providers to maintain "a permanent record of information on the safety and performance" of the system, including any incidents or malfunctions.

In the context of AI-powered healthcare tools, this means that manufacturers will be required to provide transparency on the technical design and functionality of their devices, as well as any mitigation measures taken to address identified risks. This will enable healthcare professionals, patients, and regulatory authorities to make informed decisions regarding the use and deployment of these devices.

Limitations:
Please note that this explanation is based on a general understanding of the EU AI Act and MDR, and should not be considered as legal advice. Jurisdiction is EU-wide, but member states are responsible for implementing the regulations. If you require specific guidance on the application of the EU AI Act or MDR to your AI-powered healthcare tool, I suggest consulting with a legal professional or reviewing the full text of the regulations."

**Response B:**
"To answer your question, let's break down the interaction between the EU AI Act's risk classification system and existing Medical Device Regulations for AI-powered healthcare tools, as well as the implications for transparency requirements.

Summary:
The EU AI Act's risk classification system, as outlined in Articles 7-9, classifies AI systems into high-risk, medium-risk, or low-risk categories based on their impact on health, safety, and fundamental rights. Meanwhile, the Medical Device Regulation (MDR) and the In Vitro Diagnostic Medical Device Regulation (IVDR) regulate medical devices, including those powered by AI, according to their level of risk, such as high-risk, medium-risk, or low-risk. Both systems aim to ensure safety and efficacy of medical devices, but they differ in their scope and criteria.

Step-by-step reasoning:
The EU AI Act's risk classification system for AI systems is separate from, but can intersect with, the MDR and IVDR's risk classification for medical devices. Here are some key considerations:

1. Scope: The EU AI Act focuses on AI systems as a distinct category, while the MDR and IVDR apply to medical devices, including those with AI components. AI systems can be part of medical devices, such as AI-powered diagnostic equipment, or standalone AI systems, like AI-powered health monitoring apps.
2. Classification criteria: Both systems classify risks based on the potential impact on health and safety. The EU AI Act, however, also considers fundamental rights, while the MDR and IVDR prioritize patient safety and efficacy.
3. Consequential implications for transparency requirements:
* AI-powered medical devices, classified as high-risk under MDR or IVDR, will need to comply with transparency requirements, such as CE marking, technical files, and clinical data. Manufacturers will also need to declare conformity with relevant EU harmonised standards.
* Standalone AI systems, classified as high-risk under the EU AI Act, will need to comply with transparency requirements, such as EU declaration of conformity, standardised EU declaration of conformity, and relevant EU harmonised standards.
* AI-powered medical devices, classified as medium-risk or low-risk, may have more relaxed transparency requirements, depending on their specific classification under MDR or IVRD.
* Standalone AI systems, classified as medium-risk or low-risk, will need to comply with less stringent transparency requirements.

Limitations:
* Jurisdiction: Both systems are EU-wide, but national competent authorities may apply different enforcement practices.
* Complexity: AI-powered medical devices and standalone AI systems can be complex, involving multiple stakeholders, technologies, and regulations.
* Interpretation: Regulatory interpretation and enforcement may vary among national competent authorities and manufacturers.

In conclusion, while the EU AI Act's risk classification system and the MDR and IVDR's risk classification for medical devices have distinct scopes and criteria, they both aim to ensure safety and efficacy. Manufacturers of AI-powered medical devices and standalone AI systems must navigate both systems, ensuring compliance with transparency requirements and maintaining clear communication with stakeholders.

Please note that, as a legal expert, I have relied on the retrieved EU AI Act content with relevance scores to provide a comprehensive answer. However, it is always recommended to consult the full Act and relevant regulations, as well as legal professionals, for detailed guidance on specific aspects."

**Rating Categories (1-10 scale, 10 is best):**
1. Factual Accuracy (1-10): Are the facts in the response correct/accurate?
2. Completeness (1-10): Does it address all aspects of the question with relevant provisions?
3. Legal Precision (1-10): Does it use correct legal terminology and maintain proper distinctions?
4. Hallucination Rate (1-10): Any hallucinations? (10 = no hallucinations, 1 = many hallucinations)
5. Total/Average (1-10): Calculate the average of categories 1-4

**Artifact format:**
Create a text/plain artifact with EXACTLY this structure (use these exact headers and formatting):

RESPONSE A
Factual Accuracy: [score]/10 - [one sentence justification]
Completeness: [score]/10 - [one sentence justification]
Legal Precision: [score]/10 - [one sentence justification]
Hallucination Rate: [score]/10 - [one sentence justification]
Total/Average: [score]/10

RESPONSE B
Factual Accuracy: [score]/10 - [one sentence justification]
Completeness: [score]/10 - [one sentence justification]
Legal Precision: [score]/10 - [one sentence justification]
Hallucination Rate: [score]/10 - [one sentence justification]
Total/Average: [score]/10